Novo Nordisk will discontinue its weight loss medication Saxenda in January 2027. People who currently take Saxenda for ...
The drugs can sometimes cost more than $1,000 per month out of pocket.
Saxenda, which is injected daily, is the only form of GLP-1 therapy which is reimbursed for weight loss by the HSE, free ...
It’s been nearly four years since Tim Ramsay collapsed and died in his bathroom, days after he started taking the injectable ...
Among 157,822 first-time semaglutide initiators without diabetes, 49% discontinued treatment by 12 months, defined as a ...
It’s been nearly four years since Tim Ramsay collapsed and died in his bathroom, days after he started taking the injectable ...
The injectable medication known for weight loss and diabetes treatment may even have benefits for mental health conditions, ...
Starting a GLP-1 receptor agonist was associated with significantly lower risks of death and cardiovascular events in adults ...
Nine in 10 men believe people who are overweight face stigma, with feelings of shame particularly pronounced among those aged ...
More than 200 deaths suspected of being linked to weight-loss jabs have been reported to health officials, figures suggest.
OVER 200 deaths linked to the blockbuster weight loss jabs Mounjaro and Wegovy have now been reported. There have also been 15,000 reports of “serious” adverse effects to the fat jabs, ...
Melissa Glassford, DNP, discusses clinical strategies for managing GLP-1 therapy gaps, dose titration, weight plateaus, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results